Now activated! CLEARED will enroll pts with high-risk localized, lymph node-positive or low volume HSPC (planned for treatment interruption) to receive 2 years of relugolix+darolutamide for PK studies of the combo and to assess T recovery after completion. clinicaltrials.gov/study/NCT064...

See you at Kings Back Bay on Monday 11/25/24 from 6-10 pm for BellissiMO’s Movember Fundraising Finale. There will be food, karaoke, and celebration!

Can oligometastatic prostate cancer be cured with "total therapy" including radiation to all sites of disease and hormonal therapy? Dr. Praful Ravi and I along with colleagues at Dana-Farber present data from our cohort. www.sciencedirect.com/science/arti...